Robeco Institutional Asset Management B.V. lowered its position in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 19.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 103,189 shares of the company’s stock after selling 24,603 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Avantor were worth $1,389,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in AVTR. GAMMA Investing LLC raised its holdings in shares of Avantor by 3,491.9% during the first quarter. GAMMA Investing LLC now owns 60,739 shares of the company’s stock valued at $985,000 after acquiring an additional 59,048 shares during the last quarter. UMB Bank n.a. raised its holdings in shares of Avantor by 137.9% during the first quarter. UMB Bank n.a. now owns 7,093 shares of the company’s stock valued at $115,000 after acquiring an additional 4,112 shares during the last quarter. Wedge Capital Management L L P NC raised its holdings in shares of Avantor by 20.3% during the first quarter. Wedge Capital Management L L P NC now owns 79,485 shares of the company’s stock valued at $1,288,000 after acquiring an additional 13,417 shares during the last quarter. Portside Wealth Group LLC raised its holdings in shares of Avantor by 9.0% during the first quarter. Portside Wealth Group LLC now owns 10,673 shares of the company’s stock valued at $173,000 after acquiring an additional 882 shares during the last quarter. Finally, SG Americas Securities LLC raised its holdings in shares of Avantor by 55.1% during the first quarter. SG Americas Securities LLC now owns 36,099 shares of the company’s stock valued at $585,000 after acquiring an additional 12,818 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.
Insider Activity at Avantor
In other news, CAO Steven W. Eck sold 3,476 shares of the firm’s stock in a transaction on Tuesday, August 5th. The stock was sold at an average price of $11.39, for a total transaction of $39,591.64. Following the completion of the transaction, the chief accounting officer directly owned 55,068 shares in the company, valued at $627,224.52. This trade represents a 5.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.20% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on Avantor
Avantor Trading Down 4.5%
Shares of Avantor stock opened at $13.46 on Wednesday. The firm has a market capitalization of $9.17 billion, a price-to-earnings ratio of 13.59, a PEG ratio of 4.54 and a beta of 0.98. Avantor, Inc. has a fifty-two week low of $10.82 and a fifty-two week high of $26.14. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.98. The stock has a 50 day moving average of $12.75 and a 200 day moving average of $13.47.
Avantor (NYSE:AVTR – Get Free Report) last issued its quarterly earnings data on Friday, August 1st. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.01). The business had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Avantor had a return on equity of 11.39% and a net margin of 10.31%.The company’s revenue was down 1.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.25 earnings per share. As a group, research analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current year.
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
See Also
- Five stocks we like better than Avantor
- How to Profit From Growth Investing
- EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector
- Growth Stocks: What They Are, Examples and How to Invest
- These Are the 3 Hottest Sectors for Q3 Earnings Growth
- How to find penny stocks to invest and trade
- AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.